HIV AIDS. Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases
Conditions
Interventions
Intervention 1: Experimental group1-
include 33 people, that first in pre-test, the questionnaires were distributed and collected in order to measure the variables- susceptibility (probability of ha
Prevention
Experimental group6- include 33 people, that first in pre-test, the questionnaires were distributed and collected in order to measure the variables- susceptibility (probability of harm), severity, fea
Experimental group2- include 33 people, that first in pre-test, the questionnaires were distributed and collected in order to measure the variables- susceptibility (probability of harm), severity, fea
Experimental group3- include 33 people, that first in pre-test, the questionnaires were distributed and collected in order to measure the variables- susceptibility (probability of harm), severity, fea
Experimental group4- include 33 people, that first in pre-test, the questionnaires were distributed and collected in order to measure the variables- susceptibility (probability of harm), severity, fea
Experimental group5- include 33 people, that first in pre-test, the questionnaires were distributed and collected in order to measure the variables- susceptibility (probability of harm), severity, fea
Control group - include 100 people, that first in pre-test, the questionnaires were distributed and collected in order to measure the variables- susceptibility (probability of harm), severity, fear, a
Experimental group1-
include 33 people, that first in pre-test, the questionnaires were distributed and collected in order to measure the variables- susceptibility (probability of harm), severity,
Sponsors
Vice Chancellor for research Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
14 Years to 18 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: prisoners In JCRCT; aged 14 to 18 years. Exclusion criteria: age less than 14 and more than 18 Years.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Susceptibility. Timepoint: Before and 1 week after advertisement view. Method of measurement: Measured by standardized questionnaire.;Severity. Timepoint: Before and 1 week after advertisement view. Method of measurement: Measured by standardized questionnaire.;Fear. Timepoint: Before and 1 week after advertisement view. Method of measurement: Measured by standardized questionnaire.;Behavioral Intention. Timepoint: Before and 1 week after advertisement view. Method of measurement: Measured by standardized questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Attitude Toward Advertising. Timepoint: 1 Week After Advertisement View. Method of measurement: Measured By Standardized Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMinoo Mohraz MD
Iranian research Center for HIV AIDS (IRCHA)
Outcome results
None listed